Cargando…
Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016–2019)
Acetylcholinesterase (AChE) is the key enzyme responsible for deactivating the ACh neurotransmitter. Irreversible or prolonged inhibition of AChE, therefore, elevates synaptic ACh leading to serious central and peripheral adverse effects which fall under the cholinergic syndrome spectra. To combat t...
Autores principales: | de Castro, Alexandre A., Assis, Letícia C., Soares, Flávia V., Kuca, Kamil, Polisel, Daniel A., da Cunha, Elaine F. F., Ramalho, Teodorico C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175240/ https://www.ncbi.nlm.nih.gov/pubmed/32178264 http://dx.doi.org/10.3390/biom10030436 |
Ejemplares similares
-
Understanding the Interaction Modes and Reactivity of Trimedoxime toward MmAChE Inhibited by Nerve Agents: Theoretical and Experimental Aspects
por: de Castro, Alexandre A., et al.
Publicado: (2020) -
Can Inhibitors of Snake Venom Phospholipases A(2) Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study
por: Sales, Thaís A., et al.
Publicado: (2017) -
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
por: Sales, Thais A., et al.
Publicado: (2019) -
QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
por: Santos-Garcia, Letícia, et al.
Publicado: (2018) -
Theoretical Studies Applied to the Evaluation of the DFPase Bioremediation Potential against Chemical Warfare Agents Intoxication
por: Soares, Flávia V., et al.
Publicado: (2018)